Identification of functional endothelial protein C receptor in human plasma.
Open Access
- 15 July 1997
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 100 (2), 411-418
- https://doi.org/10.1172/jci119548
Abstract
The endothelial cell protein C receptor (EPCR) binds protein C and facilitates activation by the thrombin-thrombomodulin complex. EPCR also binds activated protein C (APC) and inhibits APC anticoagulant activity. In this study, we detected a soluble form of EPCR in normal human plasma. Plasma EPCR appears to be approximately 43, 000 D, and circulates at approximately 100 ng/ml (98.4+/-27.8 ng/ml, n = 22). Plasma EPCR was purified from human citrated plasma using ion exchange, immunoaffinity, and protein C affinity chromatography. Flow cytometry experiments demonstrated that plasma EPCR bound APC with an affinity similar to that previously determined for recombinant soluble EPCR (Kdapp = 30 nM). Furthermore, plasma EPCR inhibited both protein C activation on an endothelial cell line and APC anticoagulant activity in a one-stage Factor Xa clotting assay. The physiological function of plasma EPCR is uncertain, but if the local concentrations are sufficiently high, particularly in disease states, the present data suggest that the soluble plasma EPCR could attenuate the membrane-bound EPCR augmentation of protein C activation and the anticoagulant function of APC.This publication has 43 references indexed in Scilit:
- Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptorJournal of Biological Chemistry, 1994
- Plasma Thrombomodulin in Wegener's Granulomatosis as an Indicator of Vascular InjuriesChest, 1994
- Soluble interleukin‐6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanismEuropean Journal of Immunology, 1994
- The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site.The Journal of Immunology, 1994
- Glycosaminoglycans and the regulation of blood coagulationBiochemical Journal, 1993
- [21] Protein C activationMethods in Enzymology, 1993
- The active site of thrombin is altered upon binding to thrombomodulin. Two distinct structural changes are detected by fluorescence, but only one correlates with protein C activation.Journal of Biological Chemistry, 1991
- Circulating thrombomodulin in thrombotic thrombocytopenic purpuraAmerican Journal of Hematology, 1991
- Increased thrombomodulin values in plasma of diabetic men with microangiopathyClinical Chemistry, 1991
- PLASMA THROMBOMODULIN IN HEALTH AND DISEASES1990